use of rifaximin and farmeaceutiske preparations containing rifaximin for the treatment of gastri sk dyspepsia caused by heliobacter pylori

• 1. 利福昔明在治疗由隐孢子虫病引起的腹泻中的用途 [P] . 中国专利： CN1115146C . 2003.07.23
• 2. 利福昔明在治疗由隐孢子虫病引起的腹泻中的用途 [P] . 中国专利： CN1214244A . 1999-04-21
• 3. Use of rifaximin and rifaximin - containing pharmaceutical compositions for the treatment of the stomach dyspepsia caused by helicobacter pylori [P] . 德国专利： DE69400493T2 . 1997-01-23

  机译： 利福昔明和含有利福昔明的药物组合物在治疗由幽门螺杆菌引起的胃消化不良中的用途

• 4. RIFAXIMIN AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT IN THE TREATMENT OF GASTRIC DYSPEPSIA CAUSED BY HELICOBACTER PYLORI [P] . CA2115381C . 1999-01-05

  机译： 利福昔明及其药物组合物治疗幽门螺杆菌引起的消化不良

• 5. PHARMACEUTICAL COMPOSITIONS CONTAINING RIFAXIMIN FOR THE TREATMENT OF GASTRIC DYSPEPSIA CAUSED BY HELICOBACTER PYLORI [P] . 韩国专利： KR0177846B1 . 1999-03-20

  机译： 包含利福昔明的药物组合物治疗幽门螺杆菌引起的消化不良

• 1. Rifaximin-Cefacetril Treatments of Clinical Mastitis: Efficacy of One-day Treatment Compared to Two-day Treatment [C] . Annual Meeting of The National Mastitis Council (U.S.). . 2018
• 2. Therapeutic efficacy of amoxicillin and rifaximin in patients with small intestinal bacterial overgrowth and Helicobacter pylori infection [O] . Paulina Konrad, Jan Chojnacki, Anita Gąsiorowska, 2018
• 3. Randomised clinical trial: rifaximin versus placebo for the treatment of functional dyspepsia [O] . V. P. Y. Tan, K. S. H. Liu, F. Y. F. Lam, 2017

• 1. Efficacy of long-term rifaximin treatment for hepatic encephalopathy in the Japanese [J] . Shinya Nishida ,Koichi Hamada ,Noriyuki Nishino . 世界肝病学杂志：英文版（电子版） . 2019,第6期
• 2. Rifaximin in the treatment of inflammatory bowel disease [J] . Mario Guslandi . 世界胃肠病学杂志：英文版 . 2011,第42期
• 3. 利福昔明治疗肠易激综合征疗效与安全性的Meta分析 [C] . 王霄腾 ,戴金锋 ,吕宾 . 世界中医药学会联合会消化病专业委员会第六届消化病国际学术大会 . 2015
• 4. 利福昔明联合乳果糖治疗肝性脑病的疗效：一项Meta分析 [A] . 彭琴 . 2020